The Value and Future of Prostate Brachytherapy in a Changing Healthcare Environment

December 7-8, 2013

MD Anderson Cancer Center
Dan L. Duncan Building (CPB)
Floor 8 Conference Center
1155 Pressler Street
Houston, Texas

General Information


The conference intends to convince clinicians to change to a standardized process of quality assurance for prostate brachytherapy using MRI-based treatment planning and MRI-based post-implant evaluation. We aim to remove the subjective nature of brachytherapy treatment with definable objective parameters. We further intend to define the value of prostate brachytherapy in the emerging healthcare system based on patient reported outcomes measures and standardized costing methodologies.

Target Audience

This conference should be of interest to Radiation Oncologists, Urologists, Physicists, Dosimetrists, Therapists, Nurses, and Residents.

Educational Objectives

After attending this conference, participants should be able to

  • Incorporate the model for value for prostate brachytherapy in the new healthcare environment (knowledge, competence, performance);
  • Apply a process of quality assurance in prostate brachytherapy in clinical practice (knowledge, competence, performance, patient outcomes);
  • Interpret the disease outcomes following High Dose Rate and Low Dose Rate prostate brachytherapy in practice to improve patient outcomes (knowledge, competence, performance, patient outcomes);
  • Apply quality of life outcomes in prostate brachytherapy and incorporate them into daily practice to provide optimal patient care (knowledge, competence, performance, patient outcomes);
  • Demonstrate knowledge of the management of patients with recurrent prostate cancer (knowledge, competence); and
  • Identify the role of MRI in prostate brachytherapy (knowledge, competence).

Education Methods

  • Lectures
  • Question-and-Answer Sessions
  • Case Studies
  • Panel Discussions
  • Audience Response System


A course evaluation form will provide participants with the opportunity to comment on the value of the program content to their practice decisions, performance improvement activities, or possible impact on patient health status. Participants will also have the
opportunity to comment on any perceived commercial bias in the presentations as well as to identify future educational topics.

Accreditation/Credit Designation


 The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 13.25 AMA PRA Category 1 Credits™.  Physicians should claim only credit commensurate with the extent of their participation in the activity.


Pending approval by the Medical Dosimetrist Certification Board (MDCB) for continuing education credit.


Course is pending approval by the Commission on Accreditation of Medical Physicists Education Programs (CAMPEP) of Category A continuing education credits.

CME Certificates and Attendance Verification Certificates

Certificates awarding AMA PRA Category 1 Credit™ or certificates documenting attendance will be distributed to participants when an individual departs the conference. To obtain a CME certificate, physicians must submit a completed evaluation questionnaire and a CME Verification Form.

Upon request, a record of attendance (certificate) will be provided on-site to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.

Special Assistance

Contact the Department of CME/Conference Management at 713-792-2223 or toll free at 866-849-5866 if you have any special dietary or ADA accommodation needs.

Please let us know what specific topics, issues, or questions you wish to see addressed or emphasized in this activity. Fax or e-mail CME/Conference Management. All responses will be forwarded to the Program Chair for consideration.

Photographing, audio taping, and videotaping are prohibited.